Type 1 diabetes

Current Clinical Features of Diabetic Ketoacidosis in Adults: A German Multicenter Study 2022–2023

Diabetes Technol TherPublished Multicenter observational study

Authors' conclusion

The clinical and etiological pattern of DKA is heterogeneous. Patients with pre-existing T1DM showed educational deficits concerning diagnostic and therapeutic measures to prevent DKA. Individuals with recurrent episodes of DKA require individual therapeutic concepts within the multidisciplinary diabetes care team. Emphasizing sick-day-rules in patients being treated with SGLT 2-Is is indispensable to prevent EDKA. Individuals with pre-existing T2DM represent a vulnerable group with severe comorbidities and high mortality risk due to DKA.

Study context

Population
Adults with diabetic ketoacidosis (DKA) leading to hospital admission, five German tertiary hospitals, 2022–2023
Participants
179 adults203 DKA episodes
Outcome
Clinical features of DKA
Methodological detailsfive German tertiary hospitals
  • Five German tertiary hospitals

Main finding

As reported in the abstract

Cases in pre-existing T1D
64%
Cases in new-onset T1D
14%
Cases in pre-existing T2D
14%
Cases in new-onset T2D
3%
Cases in LADA
6%
Cases in pancreatogenic diabetes
6%
SGLT2i-associated euglycemic DKA cases
7
Pre-existing T1D: DKA despite CGM
51%
Pre-existing T1D: DKA despite insulin pumps or AID
24%
T1D in possession of ketone test
21%
T1D applying ketone testing
6%
Pre-existing T1D with recurrent DKA
71%
Suboptimal adherence as trigger in known T1D
56%
Infections as trigger in pre-existing T2D
32%

Observational data: associations, not effects.

Further findings

Inpatient mortality of DKA

Inpatient mortality risk, restricted to multimorbid patients with known T2D
2.3%

Original publication

Current Clinical Features of Diabetic Ketoacidosis in Adults: A German Multicenter Study 2022–2023. Diabetes Technol Ther. Published 26 September 2025. doi:10.1177/15209156251380863

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.